[1] KIM SJ, SHETTY AA, KURIAN NM, et al. Articular cartilage repair using autologous collagen-induced chondrogenesis (ACIC): a pragmatic and cost-effective enhancement of a traditional technique. Knee Surg Sports Traumatol Arthrosc. 2020;28(8):2598-2603.
[2] LIU Y, MA Y, ZHANG J, et al. Exosomes: A Novel Therapeutic Agent for Cartilage and Bone Tissue Regeneration. Dose Response. 2019; 17(4):1559325819892702.
[3] RIFF AJ, HUDDLESTON HP, COLE BJ, et al. Autologous Chondrocyte Implantation and Osteochondral Allograft Transplantation Render Comparable Outcomes in the Setting of Failed Marrow Stimulation. Am J Sports Med. 2020;48(4):861-870.
[4] GUGJOO MB, AMARPAL A, SHARMA GT, et al. Cartilage tissue engineering: Role of mesenchymal stem cells along with growth factors & scaffolds. Indian J Med Res. 2016;144(3):339-347.
[5] PUNWAR S, KHAN WS. Mesenchymal stem cells and articular cartilage repair: clinical studies and future direction. Open Orthop J. 2011;5 Suppl 2:296-301.
[6] PELTTARI K, WINTER A, STECK E, et al. Premature induction of hypertrophy during in vitro chondrogenesis of human mesenchymal stem cells correlates with calcification and vascular invasion after ectopic transplantation in SCID mice. Arthritis Rheum. 2006;54(10): 3254-3266.
[7] LOLLI A, PENOLAZZI L, NARCISI R, et al. Emerging potential of gene silencing approaches targeting anti-chondrogenic factors for cell-based cartilage repair. Cell Mol Life Sci. 2017;74(19):3451-3465.
[8] RAGNI E, PERUCCA ORFEI C, DE LUCA P, et al. Secreted Factors and EV-miRNAs Orchestrate the Healing Capacity of Adipose Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis. Int J Mol Sci. 2020;21(5):1582.
[9] LIN W, XU L, LIN S, et al. Characterisation of multipotent stem cells from human peripheral blood using an improved protocol. J Orthop Translat. 2019;19:18-28.
[10] PIÑEIRO-RAMIL M, SANJURJO-RODRÍGUEZ C, CASTRO-VIÑUELAS R, et al. Usefulness of Mesenchymal Cell Lines for Bone and Cartilage Regeneration Research. Int J Mol Sci. 2019;20(24):6286.
[11] JAIN A, KHADWAL A, SACHDEVA MUS, et al. Variables affecting the presence of mesenchymal stromal cells in peripheral blood and their relationship with apheresis products. Br J Haematol. 2020;189(4):772-776.
[12] LOTFY A, EL-SHERBINY YM, CUTHBERT R, et al. Comparative study of biological characteristics of mesenchymal stem cells isolated from mouse bone marrow and peripheral blood. Biomed Rep. 2019;11(4): 165-170.
[13] KIM J, SHAPIRO L, FLYNN A. The clinical application of mesenchymal stem cells and cardiac stem cells as a therapy for cardiovascular disease. Pharmacol Ther. 2015;151:8-15.
[14] DABROWSKA S, ANDRZEJEWSKA A, LUKOMSKA B, et al. Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles. J Neuroinflammation. 2019;16(1):178.
[15] GU J, HUANG L, ZHANG C, et al. Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial. Stem Cell Res Ther. 2020;11(1):43.
[16] GUGJOO MB, HUSSAIN S, AMARPAL A, et al. Mesenchymal Stem Cell-Mediated Immuno-Modulatory and Anti- Inflammatory Mechanisms in Immune and Allergic Disorders. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):3-14.
[17] IIJIMA H, ISHO T, KUROKI H, et al. Effectiveness of mesenchymal stem cells for treating patients with knee osteoarthritis: a meta-analysis toward the establishment of effective regenerative rehabilitation. NPJ Regen Med. 2018;3:15.
[18] GARZA JR, CAMPBELL RE, TJOUMAKARIS FP, et al. Clinical Efficacy of Intra-articular Mesenchymal Stromal Cells for the Treatment of Knee Osteoarthritis: A Double-Blinded Prospective Randomized Controlled Clinical Trial. Am J Sports Med. 2020;48(3):588-598.
[19] BASTOS R, MATHIAS M, ANDRADE R, et al. Intra-articular injections of expanded mesenchymal stem cells with and without addition of platelet-rich plasma are safe and effective for knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2018;26(11):3342-3350.
[20] FREITAG J, BATES D, WICKHAM J, et al. Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial. Regen Med. 2019;14(3):213-230.
[21] RANMUTHU CDS, RANMUTHU CKI, KHAN WS. Evaluating the Current Literature on Treatments Containing Adipose-Derived Stem Cells for Osteoarthritis: a Progress Update. Curr Rheumatol Rep. 2018;20(11):67.
[22] DRAGANSKI E, DEASON T, CRAIG FE. Bone Marrow Aspiration and Biopsy Performed by RNs: A Review of Clinical Practice. Am J Nurs. 2019;119(9):47-53.
[23] 杨春水,杨志刚,李建英,等.成人外周血间充质干细胞诱导为神经元样细胞的体外研究[J].交通医学,2010,24(6):602-604.
[24] WANG SJ, JIANG D, ZHANG ZZ, et al. Chondrogenic Potential of Peripheral Blood Derived Mesenchymal Stem Cells Seeded on Demineralized Cancellous Bone Scaffolds. Sci Rep. 2016;6:36400.
[25] SATO K, YAMAWAKI-OGATA A, KANEMOTO I, et al. Isolation and characterisation of peripheral blood-derived feline mesenchymal stem cells. Vet J. 2016;216:183-188.
[26] CASADO JG, GOMEZ-MAURICIO G, ALVAREZ V, et al. Comparative phenotypic and molecular characterization of porcine mesenchymal stem cells from different sources for translational studies in a large animal model. Vet Immunol Immunopathol. 2012;147(1-2):104-112.
[27] LYAHYAI J, MEDIANO DR, RANERA B, et al. Isolation and characterization of ovine mesenchymal stem cells derived from peripheral blood. BMC Vet Res. 2012;8:169.
[28] SPAAS JH, DE SCHAUWER C, CORNILLIE P, et al. Culture and characterisation of equine peripheral blood mesenchymal stromal cells. Vet J. 2013;195(1):107-113.
[29] CHONG PP, SELVARATNAM L, ABBAS AA, et al. Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells. J Orthop Res. 2012;30(4):634-642.
[30] KASSIS I, ZANGI L, RIVKIN R, et al. Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads. Bone Marrow Transplant. 2006;37(10):967-976.
[31] FU Q, ZHANG Q, JIA LY, et al. Isolation and Characterization of Rat Mesenchymal Stem Cells Derived from Granulocyte Colony-Stimulating Factor-Mobilized Peripheral Blood. Cells Tissues Organs. 2015 -2016; 201(6):412-422.
[32] FU WL, ZHOU CY, YU JK. A new source of mesenchymal stem cells for articular cartilage repair: MSCs derived from mobilized peripheral blood share similar biological characteristics in vitro and chondrogenesis in vivo as MSCs from bone marrow in a rabbit model. Am J Sports Med. 2014;42(3):592-601.
[33] ZHAO D, LI Y, ZHOU X, et al. Peripheral Blood Mesenchymal Stem Cells Combined with Modified Demineralized Bone Matrix Promote Pig Cartilage Defect Repair. Cells Tissues Organs. 2018;206(1-2):26-34.
[34] KUZNETSOV SA, MANKANI MH, GRONTHOS S, et al. Circulating skeletal stem cells. J Cell Biol. 2001;153(5):1133-1140.
[35] FERNÁNDEZ M, SIMON V, HERRERA G, et al. Detection of stromal cells in peripheral blood progenitor cell collections from breast cancer patients. Bone Marrow Transplant. 1997;20(4):265-271.
[36] READING L, STILL K, BISHOP N, et al. Peripheral blood as an alternative source of mesenchymal stem cells. J Bone Mineral Res. 2000;15(6): 1239-1239.
[37] HOPPER N, WARDALE J, BROOKS R, et al. Peripheral Blood Mononuclear Cells Enhance Cartilage Repair in in vivo Osteochondral Defect Model. PLoS One. 2015;10(8):e0133937.
[38] 赵岚,季洲,张锐,等.β-联蛋白促进大鼠外周血间充质干细胞存活及扩增[J].中国生物化学与分子生物学报,2019,35(8):880-887.
[39] LI Z, CHEN S, MA K, et al. Comparison of different methods for the isolation and purification of rat nucleus pulposus-derived mesenchymal stem cells. Connect Tissue Res. 2019:1-9.
[40] SPAAS JH, OOSTERLINCK M, BROECKX S, et al. Treatment of equine degenerative joint disease with autologous peripheral blood-derived mesenchymal stem cells: A case report. Vlaams Diergeneeskundig Tijdschrift. 2012;81(1):11-15.
[41] BROECKX S, SULS M, BEERTS C, et al. Allogenic mesenchymal stem cells as a treatment for equine degenerative joint disease: a pilot study. Curr Stem Cell Res Ther. 2014;9(6):497-503.
[42] BROECKX S, BORENA BM, ZIMMERMAN M, et al. Intravenous application of allogenic peripheral blood-derived mesenchymal stem cells: a safety assessment in 291 equine recipients. Curr Stem Cell Res Ther. 2014;9(6):452-457.
[43] BROECKX SY, SEYS B, SULS M, et al. Equine Allogeneic Chondrogenic Induced Mesenchymal Stem Cells Are an Effective Treatment for Degenerative Joint Disease in Horses. Stem Cells Dev. 2019;28(6): 410-422.
[44] BROECKX SY, MARTENS AM, BERTONE AL, et al. The use of equine chondrogenic-induced mesenchymal stem cells as a treatment for osteoarthritis: A randomised, double-blinded, placebo-controlled proof-of-concept study. Equine Vet J. 2019;51(6):787-794.
[45] DAEMS R, VAN HECKE L, SCHWARZKOPF I, et al. A Feasibility Study on the Use of Equine Chondrogenic Induced Mesenchymal Stem Cells as a Treatment for Natural Occurring Osteoarthritis in Dogs. Stem Cells Int. 2019;2019:4587594.
[46] DEBOSSCHERE Y, DEPUYDT E, PAUWELYN G, et al. Safety and immunomodulatory properties of equine peripheral blood-derived mesenchymal stem cells in healthy cats. Vet Immunol Immunopathol. 2020;227:110083.
[47] VEBER M, VOGLER J, KNEŽEVIĆ M, et al. Combination of Filtered Bone Marrow Aspirate and Biomimetic Scaffold for the Treatment of Knee Osteochondral Lesions: Cellular and Early Clinical Results of a Single Centre Case Series. Tissue Eng Regen Med. 2020;17(3):375-386.
[48] FU WL, AO YF, KE XY, et al. Repair of large full-thickness cartilage defect by activating endogenous peripheral blood stem cells and autologous periosteum flap transplantation combined with patellofemoral realignment. Knee. 2014;21(2):609-612.
[49] ARSHI A, PETRIGLIANO FA, WILLIAMS RJ, et al. Stem Cell Treatment for Knee Articular Cartilage Defects and Osteoarthritis. Curr Rev Musculoskelet Med. 2020;13(1):20-27.
[50] JAFRI MA, KALAMEGAM G, ABBAS M, et al. Deciphering the Association of Cytokines, Chemokines, and Growth Factors in Chondrogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells Using an ex vivo Osteochondral Culture System. Front Cell Dev Biol. 2020;7:380.
[51] CHEN S, FU P, CONG R, et al. Strategies to minimize hypertrophy in cartilage engineering and regeneration. Genes Dis. 2015;2(1):76-95.
[52] BOS PK, VAN OSCH GJ, FRENZ DA, et al. Growth factor expression in cartilage wound healing: temporal and spatial immunolocalization in a rabbit auricular cartilage wound model. Osteoarthritis Cartilage. 2001;9(4):382-389.
[53] BRANLY T, BERTONI L, CONTENTIN R, et al. Characterization and use of Equine Bone Marrow Mesenchymal Stem Cells in Equine Cartilage Engineering. Study of their Hyaline Cartilage Forming Potential when Cultured under Hypoxia within a Biomaterial in the Presence of BMP-2 and TGF-ß1. Stem Cell Rev Rep. 2017;13(5):611-630.
[54] FAN L, CHEN J, TAO Y, et al. Enhancement of the chondrogenic differentiation of mesenchymal stem cells and cartilage repair by ghrelin. J Orthop Res. 2019;37(6):1387-1397.
[55] 陈松,符培亮,丛锐军,等.TGF-β3、BMP-2及地塞米松诱导兔滑膜MSCs成软骨分化的研究[J].中国修复重建外科杂志,2014,28(1): 92-99.
[56] CHIJIMATSU R, KOBAYASHI M, EBINA K, et al. Impact of dexamethasone concentration on cartilage tissue formation from human synovial derived stem cells in vitro. Cytotechnology. 2018;70(2):819-829.
[57] LONGHINI ALF, SALAZAR TE, VIEIRA C, et al. Peripheral blood-derived mesenchymal stem cells demonstrate immunomodulatory potential for therapeutic use in horses. PLoS One. 2019;14(3):e0212642.
|